PERL: A multicenter clinical trial of allopurinol

Project: Research project

Project Details

Description

PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
StatusActive
Effective start/end date9/15/176/30/20

Funding

  • JOSLIN DIABETES CENTER, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.